March 29, 2026 - 22:31

The autonomous vehicle unit Zoox, owned by Amazon, is significantly ramping up its real-world operations. The company has expanded its testing to new cities and is operating its purpose-built, driverless robotaxis on public roads for employee use. This marks a period of intense technical development and data collection for the ambitious startup.
Despite this operational momentum, Zoox is not yet generating meaningful commercial revenue. The company remains deep in an expensive research and development phase, focusing on refining its technology and ensuring safety before a broader public launch. The current rider base is limited to employees, and the service is not available to paying customers.
The path forward involves scaling its fleet and navigating complex regulatory approvals in each new market. While the expansion demonstrates confidence in its technology, industry observers note that the leap from testing to a sustainable, profitable business is a formidable challenge. The company continues to burn significant capital with the long-term bet that its unique, symmetrical vehicle design and full-stack approach will eventually lead to a commercial breakthrough in the competitive robotaxi sector.
August 16, 2026 - 03:58
Iran business leader admits U.S. blockade will inflict more economic damage than war, and the ‘worst thing that could happen’ is trying to evade itThe head of the Iran-China Joint Chamber of Commerce has made a rare public admission that the ongoing U.S. economic blockade will cause more damage to Iran`s economy than a direct military...
August 15, 2026 - 03:30
Despite Mamdani’s Attempts to Appease, Many Business Leaders Remain WaryThe mayor`s latest effort to build a bridge to the business community is off to a rocky start. An attempt to form a new advisory council has run into resistance, as several prominent executives...
August 14, 2026 - 22:25
FDA approves new Alzheimer’s PET imaging agent from LantheusThe U.S. Food and Drug Administration has approved a new imaging agent designed to help diagnose Alzheimer`s disease in adults. The drug, sold under the brand name Tauklarify and developed by...
August 14, 2026 - 01:18
Forbes editor out; report says he took $6M from founder of firm that does business with magazineThe top editor at Forbes is out of his role following a report that he received millions of dollars from a man whose company regularly works with the magazine. The New York Times detailed this week...